Navigation Links
Case Western Reserve receives $1.6M to study tumor cells and immune cell detection
Date:3/31/2011

Case Western Reserve University School of Medicine has received a $1.6 million grant from the National Cancer Institute (NCI) to study how tumor cells avoid detection by the body's immune system, allowing cancer to develop and spread.

The five-year National Institutes of Health grant will enable researchers led by Alex Y. Huang, MD, PhD, assistant professor of pediatrics, pathology, and biomedical engineering at the School of Medicine, and a hematologist and oncologist at Rainbow Babies & Children's Hospital at University Hospitals Case Medical Center, to examine "immune tolerance." The process keeps tumor cells from being detected by the immune system, even when they invade draining lymph nodes, a place where primary immune activation and surveillance take place. Lymph nodes are part of the body's lymphatic system, which fights off viruses, bacteria, and other disease-causing agents.

The study will also test whether modifying the environment in which tumor and immune cell interactions take place, using a group of proteins called inflammatory chemokines, will activate unresponsive immune cells into fighting off cancer. Using inflammatory chemokines as part of the anti-tumor strategies is a novel approach to cancer treatment.

"This research will provide greater insight into the potential therapeutic utilities of inflammatory chemokines, thereby providing a new direction for the development of immunotherapies that are capable of fighting cancer at the most basic cellular level," Dr. Huang says, who is also an associate member of the Case Comprehensive Cancer Center at the School of Medicine and director of the Pediatric Hematology-Oncology Fellowship Program at Rainbow Babies & Children's Hospital. "Any effective cellular immunotherapy must enhance long-term tumor immunity, effectively concentrating immune cells and priming them to destroy cancer cells anywhere in the body over long periods of time."

Researchers will work to leverage the immune system's unique ability to generate immune memory to eradicate any future cancer cell development that is derived from a primary tumor, according to Dr. Huang. They will use an advanced imaging technique called intravital 2-photon laser scanning microscopy to directly visualize tumor and immune cell interactions in real-time.

Dr. Huang's laboratory has been at the forefront of developing this imaging technology, which he says provides a "court-side" view of how tumors and the immune system interact with one another within intact tissue as cancer spreads to the lymph nodes. The technology is designed to provide a powerful in vivo experimental platform to monitor future anti-cancer or immunotherapy approaches, as opposed to static tissue analysis or single-cell analysis on a plastic petri dish, he explains.

Dr. Huang's research is among the first attempts to directly visualize the tolerance of immune cells by metastatic cancer cells in the draining lymph node at a cellar level, in a dynamic fashion.

As a practicing pediatric hematologist and oncologist, Dr. Huang aims to one day be able to apply the scientific insight gained from this research in a pediatric care setting.


'/>"/>

Contact: Jessica Studeny
jessica.studeny@case.edu
216-368-4692
Case Western Reserve University
Source:Eurekalert

Related medicine news :

1. UT Southwestern research advances fight against kidney cancer
2. Annual sonograms are needed to verify correct IUD position, UT Southwestern obstetricians say
3. Northwestern Medicine multiple sclerosis program earns national designation
4. UT Southwestern receives $36.7 million for cancer research
5. Foster parents receive more support than kinship caregivers, UT Southwestern study finds
6. UT Southwestern launches clinical trial for treatment of breast cancer using CyberKnife
7. Homogeneous tuberculosis treatment ineffective in children, UT Southwestern researchers find
8. Western Diet May Raise Risk of Kidney Function Decline
9. Helping others helps alcoholics stay on the road to recovery, Case Western Reserve shows
10. Case Western Reserve receives $7.8M to study manic symptoms in children
11. Case Western Reserve and Athersys show regenerative benefit of MultiStem after spinal cord injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... The American Speech-Language-Hearing Association ... a critical part of public access to hearing aid technology. , ASHA emphasized ... week that, starting immediately, it would no longer enforce the requirement that ...
(Date:12/9/2016)... ... December 09, 2016 , ... "I have gout, and I wanted to ... recipe, which is meant to relieve gout and pain caused by varicose veins. I ... boost every time. It relieved what VA doctors called the worst sinusitis case they'd ...
(Date:12/9/2016)... ... December 09, 2016 , ... Mediaplanet today announces distribution of the latest edition ... to sign up as an organ donor for the 123,000 people in the United ... donor can save up to 8 saves through organ donation and enhance many others ...
(Date:12/9/2016)... ... December 09, 2016 , ... The Pennsylvania Athletic ... (PCN) during the summer of 2016. The program was made possible by a ... States Department of Health and Human Services Administration. The broadcast, Use Your ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... LLC, announced the first national #QuackGivesBack campaign which supported local breast cancer organizations ... first franchise-wide Quack Gives Back initiative, and we’re very pleased with ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 Global ... report on the global interventional radiology market analyzes ... The report comprises an elaborate executive summary, including ... various segments and sub-segments. The research is ... research formed the bulk of our research efforts ...
(Date:12/8/2016)... -- Eli Lilly and Company (NYSE: LLY ) ... trial at the 9 th Clinical Trials on ... not meet the primary endpoint in the EXPEDITION3 clinical ... mild dementia due to Alzheimer,s disease (AD), and Lilly ... treatment of mild dementia due to AD. ...
(Date:12/8/2016)... Dec. 8, 2016 Bodycad announced it ... improving the accuracy, reproducibility and speed for 3D ... and small bone orthopaedic applications. These patents are ... personalized orthopaedic restorations based on each patient,s distinct ... the company harnesses the world,s first suite of ...
Breaking Medicine Technology: